The Latest

uMETHOD Health recognized in local news

The News and Observer, a daily newspaper serving the Triangle area in Raleigh, NC, has a feature article on uMETHOD’s unique AI approach to Alzheimer’s disease. The paper is the second largest in the state and has been awarded multiple Pulitzer Prizes. Ray Gronberg wrote the article titled “Can AI give hope to Alzheimer’s patients? This Raleigh start-up says yes.” To read the full article, click here.…READ MORE

Two Steps Forward, One Back In Alzheimer’s and Brain Awareness Month

Alzheimer's and Brain Awareness Month may have come to a close, but the important work of finding treatments continues. Despite drug development setbacks, several major announcements made during June will have a positive impact. On June 25th AARP announced a $60 million investment in the Dementia Defense Fund (DDF), an impact-driven venture capital fund that invests in innovative ideas related to dementia. With this donation, the DDF was able to…READ MORE

uMETHOD Launches Refreshed Branding and Website

uMETHOD, a healthcare technology company that makes precision medicine practical for physician practices, has launched a new website and updated its branding. The new brand which includes the tagline, Treatment Paths. Made Personal., reflects the company’s focus on using unique patient medical data and artificial intelligence to allow physicians to provide personalized care plans for their patients. The first offering from uMETHOD is the RestoreU METHOD for patients with memory…READ MORE

uMETHOD Health Announces Multiple Presentations at the 2018 AAIC

The Alzheimer’s Association International Conference (AAIC) is the largest international meeting dedicated to Alzheimer’s and dementia. It brings together researchers, physicians, and companies from all over the world to present and discuss the latest research and breakthroughs. uMETHOD Health will be attending AAIC for the third year in a row this July 22-26th. Our poster presentations this year include: Observations on the Frequency of Depression and Medications in an APOE…READ MORE

The Pink Ceiling Invests in uMETHOD

uMETHOD, a precision medicine company that uses artificial intelligence and unique patient medical information to address the multiple causes of chronic diseases, recently announced an investment from The Pink Ceiling.   The company’s initial solution, the RestoreU METHOD, targets Alzheimer’s Disease. “Two-thirds of people suffering from Alzheimer’s are women and two-thirds of the caregivers are women.” says uMETHOD co-founder and CEO Vik Chandra. “As the population ages, Alzheimer’s will become…READ MORE